These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ten years after: "I'd love to change the world". Tommaso CL Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115 [No Abstract] [Full Text] [Related]
7. Clopidogrel treatment and the MEND-CABG II trial. Oh J; Hong N; Kang SM JAMA; 2008 Sep; 300(9):1021; author reply 1021-2. PubMed ID: 18768409 [No Abstract] [Full Text] [Related]
8. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release. Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592 [TBL] [Abstract][Full Text] [Related]
9. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit. Leesar MA Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148 [No Abstract] [Full Text] [Related]
10. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Kones R Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829 [TBL] [Abstract][Full Text] [Related]
11. Meta-analyses with rare events should use adequate methods. Kuss O; Gummert JF; Börgermann J J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241. PubMed ID: 18603107 [No Abstract] [Full Text] [Related]
12. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials. Saha SA; Molnar J; Arora RR J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946 [TBL] [Abstract][Full Text] [Related]
13. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)]. Strasser RH Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057 [No Abstract] [Full Text] [Related]
16. No cardiovascular help from B vitamins in high-risk women. Harv Womens Health Watch; 2008 Sep; 16(1):7. PubMed ID: 18807631 [No Abstract] [Full Text] [Related]
17. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery. Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540 [TBL] [Abstract][Full Text] [Related]
18. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998 [TBL] [Abstract][Full Text] [Related]
19. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046 [TBL] [Abstract][Full Text] [Related]
20. Stents versus bypass grafting for left main coronary artery disease. Arnold JR; Banning AP N Engl J Med; 2008 Jul; 359(4):424-5; author reply 425. PubMed ID: 18655246 [No Abstract] [Full Text] [Related] [Next] [New Search]